Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away.
That’s the vision of the field of bioelectronic medicine — the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News(C&EN), the weekly news magazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.
Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.
The Latest on: Bioelectronics
[google_news title=”” keyword=”Bioelectronics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioelectronics
- Five Aussie startups that raised $163.6 million this weekon May 16, 2024 at 5:57 pm
Find out more about five Aussies startups that collectively raised $163.6 million this week, including a former Smart50 Awards winner!
- New Breakthrough Paves the Way for Vision Implants That Can Restore Sighton May 15, 2024 at 8:58 pm
A remarkably small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the ...
- Tivic Reports First Quarter 2024 Financial Results and Subsequent Eventson May 15, 2024 at 5:26 pm
Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it ...
- The Gentle Prick: Sea Slug-Inspired Stretchable Microneedles Revolutionize Biomedical Sensorson May 15, 2024 at 3:11 am
Highly stretchable and customizable microneedles that revolutionize the interface between human bodies and invasive monitoring devices have been developed through USC research. They are promising for ...
- Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technologyon April 25, 2024 at 12:00 am
a bioelectronics BCI technology company. The transaction was announced in a Science blog post by CEO and co-founder Max Hodak, who said: “The PRIMA retinal implant, developed by Pixium and based ...
- Understanding Bioelectronics: The Intersection of Biology and Electronicson March 9, 2024 at 4:39 am
Definition: Bioelectronics is an interdisciplinary field that blends biology with electronics, focusing on the development and application of electronic devices and technologies to biology and ...
- MAT_SCI 353: Bioelectronicson November 14, 2019 at 10:05 pm
BME/MSE 353 covers the materials, device, and some systems level design of bioelectronics for wearable and implantable applications. Significant focus will be placed on the characteristics at the ...
- The Shocking Biotech Applications Of Electric Bacteriaon June 24, 2019 at 8:50 pm
These electric filaments could be used for applications such as biosensors and bioelectronics. The filaments could be harnessed as "a revolutionary, sustainably produced, electronic material with ...
- BME 353: Bioelectronicson January 18, 2019 at 2:25 am
BME/MSE 353 covers the materials, device, and some systems level design of bioelectronics for wearable and implantable applications. Significant focus will be placed on the characteristics at the ...
- BioElectronics Corp.on April 16, 2018 at 10:15 am
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
via Bing News